Samuel George A. III - Insider Non-Derivative Transactions at Lineage Cell Therapeutics, Inc. (LCTX) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Dec 19, 2025, Samuel George A. III's relationship to Lineage Cell Therapeutics, Inc. (LCTX) is Officer (General Counsel and Secretary), and currently has 9,674 shares of Common Shares, no par value, and 27,555 shares of Common Shares.

The charts below show the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other LCTX insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Samuel George A. III - Insider Non-Derivative Transactions of LCTX Common Shares, no par value

Samuel George A. III - Insider Non-Derivative Transactions of LCTX Common Shares

Samuel George A. III - Insider Non-Derivative Transactions at LCTX

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Dec 20, 2025	F -- (Common Shares)	65	1.68	27490
Dec 20, 2025	Acquisition -- (Common Shares)	1735	0	27555
Feb 12, 2025	F -- (Common Shares)	2440	0.65	25820
Feb 12, 2025	M -- (Common Shares)	6076	0	28260
Nov 27, 2024	P -- (Common Shares)	15000	0.6	22184
Feb 12, 2024	F -- (Common Shares, no par value)	2490	1.08	7184
Feb 12, 2024	M -- (Common Shares, no par value)	6076	0	9674
Feb 12, 2023	F -- (Common Shares, no par value)	2478	1.35	3598
Feb 12, 2023	M -- (Common Shares, no par value)	6076	0	6076